MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0024387
Indian Genomix Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹23.72 Cr
▲ 6% YoY
Net profit · FY 2025
₹45.41 Lakh
Net margin 1.9%
EBITDA · FY 2025
₹1.9 Cr
EBITDA margin 8%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.28 Cr
Issued & subscribed
Open charges
₹7.89 Cr
Secured borrowings
Company age
28 yrs
Est. 1998
Employees · EPFO
110
Provident fund records
About Indian Genomix Private Limited
Data last updated:
Indian Genomix Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 23 December 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1998PTC030757. Its GSTIN is 36AAACI7203A1Z8 (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.28 Cr. It is led by directors Anil Kumar Muppala and Naga Bhushanam Muppala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.135/1 & 2 Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.72 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹45.41 Lakh (net margin 1.9%) and EBITDA of ₹1.9 Cr (EBITDA margin 8%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 8% over five years.
The company has about 110 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Indian genomix. As per MCA filings, the company has open charges of ₹7.89 Cr on record. Court records list 4 cases involving the company, including 4 filed against it; 2 cases are pending.
Indian Genomix Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0024387). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indiangenomix.co.in.
Company details
CIN U24230TG1998PTC030757
Registration Number 030757
Incorporation Date 23 December 1998
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0024387
CIN history
Indian Genomix has one previous CIN (Corporate Identification Number): U24230AP1998PTC030757. The current CIN is U24230TG1998PTC030757, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1998PTC030757 | Current |
| U24230AP1998PTC030757 | Previous |
Recognitions & Rankings of Indian Genomix
Contact details
Indian Genomix Private Limited's registered office is in Hyderabad, Telangana. Its website is indiangenomix.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.135/1 & 2 Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Indian Genomix Private Limited, buy the company report.
Comprehensive company report
Indian Genomix Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Indian Genomix operates one associated brand: Indian genomix. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulation manufacturing and marketing in India. | indiangenomix.com |
Business activity
The main business activity of Indian Genomix is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Indian Genomix Private Limited, buy the company report.
Financials of Indian Genomix Private Limited
FY 2025 filings availableIndian Genomix Private Limited reported revenue of ₹23.72 Cr (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹23.72 Cr ▲ 6%
Net profit · FY 2025
₹45.41 Lakh margin 1.9%
EBITDA · FY 2025
₹1.9 Cr margin 8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 6%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 5%
5 years · compounded
▲ 2%
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 6% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.9 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹45.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indian Genomix Private Limited, buy the company report.
Board of directors of Indian Genomix Private Limited
Indian Genomix has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Muppala | Director | 23 Dec 1998 | 27 Years 10 Months | Current |
| Naga Bhushanam Muppala | Director | 23 Dec 1998 | 27 Years 10 Months | Current |
Peer comparison
Indian Genomix Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Akron Parentarals Private Limited | ₹25.9 Cr (FY 2025) | 26.0% | Muppalla, Andhra Pradesh, India | |||
| Bushal Chemi-Pharma Private Limited | ₹25.58 Cr (FY 2025) | 3.0% | Badlapur, Maharashtra, India | |||
| Indian Genomix Private Limitedthis company | ₹23.72 Cr (FY 2025) | ₹45.41 Lakh | 1.9% | 6.0% | 110 | Hyderabad, Telangana, India |
| Gentle Bio-Sciences Private Limited | ₹23.7 Cr (FY 2024) | -12.0% | Hyderabad, Telangana, India | |||
| Vibro Pharma Private Limited | ₹23.45 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Konar Organics Limited | ₹23.36 Cr (FY 2025) | -3.0% | Hyderabad, Telangana, India | |||
| Interface Pharmaceuticals Pvt Ltd | ₹22.92 Cr (FY 2025) | 13.0% | New Delhi, Delhi, India |
To see the full peer comparison of Indian Genomix Private Limited, buy the company report.
Auditor
Indian Genomix Private Limited is audited by Guduru Sreenivasa Rao And Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Guduru Sreenivasa Rao And Co | FY 2023 | 025239S |
Shareholding
The shareholding of Indian Genomix Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Indian Genomix Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7.89 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Nov 2004 | 90259032 | State Bank of India | ₹7.89 Cr | Open |
To see the full charge records of Indian Genomix Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Indian Genomix Private Limited has 4 court cases on record: 4 filed against it. 2 cases are pending and 2 are disposed.
Total cases
4
Filed against the company
4
Pending
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 2 |
| High courts | 1 | 1 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed against the company by M/S Symbiosis Pharmaceuticals Pvt Ltd | Disposed |
| District court, Medchal Malkajgiri, Telangana | Criminal complaint | Filed against the company by State of Telangana Drug Inspector | Pending |
| District court, Pune, Maharashtra | Civil suit | Filed against the company by State at the Instance of Mr. S.V. Pratapwar, Drugs Inspector, | Pending |
| District court, Krishna, Andhra Pradesh | Court case (SC.SPL) | Filed against the company by The State of Andhra Pradesh Rep.By the Drgus Inspector, | Disposed |
To see the full case history of Indian Genomix Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indian Genomix Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Indian Genomix Private Limited has a workforce of 110 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
Employee count
110
Active EPFO establishments
1
Employee growth
-4.35%
GST
Indian Genomix has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACI7203A1Z8 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Indian Genomix Private Limited, buy the company report.
Recent activity
Indian Genomix Private Limited has 2 board changes on record since 1998: 2 appointments. The latest: Anil Kumar Muppala was appointed as Director on 23 Dec 1998.
AGM
Indian Genomix Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Indian Genomix Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with State Bank Of India of Rs. 7.89 Cr registered on 05 Nov 2004 with Charge ID 90259032 was modified on 16 Dec 2022.
Charges
A charge with State Bank Of India amounted to Rs. 7.89 Cr with Charge ID 90259032 was registered on 05 Nov 2004.
Appointed
Anil Kumar Muppala was appointed as Director.
Appointed
Naga Bhushanam Muppala was appointed as Director.
Incorporation
23 Dec 1998
Indian Genomix Private Limited was registered on 23 Dec 1998 with Roc Hyderabad & aged 27 years 10 months as per MCA records.
Frequently asked questions
Indian Genomix is an active private limited company based in Hyderabad, Telangana, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 23 December 1998 (28+ years old) and is registered under CIN U24230TG1998PTC030757.
Indian Genomix has 2 current directors:
- Anil Kumar Muppala - Director
- Naga Bhushanam Muppala - Director
The latest financial statements of Indian Genomix on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Indian Genomix is 36AAACI7203A1Z8, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Indian Genomix is U24230TG1998PTC030757. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indian Genomix has 4 court cases on record: 4 filed against it. 2 are pending. Most are in the district courts.
Indian Genomix was incorporated on 23 December 1998, making it 28+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Indian Genomix by revenue are Akron Parentarals Private Limited, Bushal Chemi-Pharma Private Limited, Gentle Bio-Sciences Private Limited, Vibro Pharma Private Limited, Konar Organics Limited and 1 more, all in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anil Kumar Muppala was appointed as Director on 23 Dec 1998. Naga Bhushanam Muppala was appointed as Director on 23 Dec 1998.
Yes, Indian Genomix is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0024387).
Indian Genomix can be reached through the website indiangenomix.co.in. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages